FansUnite Buys American Affiliate For US$58.2 Million
FansUnite Entertainment (CSE: FANS) announced today that it has acquired the gambling media portfolio, American Affiliate. The acquisition is reported to be for total consideration of US$58.2 million. According to the terms of the agreement, the acquisition price is comprised of US$13.5 million in cash paid upon closing, US$41.7 million in common shares at $0.75 per […]
Organigram Posts Q4 Loss Of $26.0 Million
Organigram Holdings (TSX: OGI) this morning reported its fiscal fourth quarter financial results, posting net revenues of $24.9 million. The company also posted a loss of $26.0 million for the three month period. Revenues were up considerably on a quarter over quarter basis, climbing 22% from $20.3 million to $24.9 million. Recreational cannabis reportedly accounted […]
White House Announces Release Of 50 Million Barrels of Oil From Reserve In Parallel With China, Japan, India, Others
The White House announced today that the country’s Department of Energy is making available releases of 50 million barrels of oil from the Strategic Petroleum Reserve. The move is aimed “to lower prices for Americans and address the mismatch between demand exiting the pandemic and supply”. In August 2021, US President Joe Biden asked the […]
Empower Clinics Posts Revenues Of $0.4 Million For Q3
Empower Clinics (CSE: CBDT) this morning reported its third quarter financial results, posting revenues of $0.4 million for the three month period. Revenues were down substantially on a quarter over quarter basis, yet the company managed to post a positive net income of $2.3 million. Revenues fell a whopping 52.9% on a quarter over quarter […]
Compass Pathways Granted Its Tenth Overall Patent Related To Psilocybin
Compass Pathways (NASDAQ: CMPS) this morning issued a brief release, indicating it has been granted a fifth patent in the United States. The patent is related to what is referred to as crystalline psilocybin. More specifically, the patent covers methods of treating treatment-resistant depression through the use of crystalline psilocybin. The patent also covers the […]
Sprott Physical Uranium Trust Announces A US$1.2 Billion At-The-Market Financing
Demand for physical uranium appears to be picking up again. The Sprott Physical Uranium Trust (TSX: U.UN), which is commonly referred to as SPUT, last night filed a prospectus supplement, indicating it will be conducting yet another round of an at-the-market equity program. The latest program is pegged at US$1.2 billion, and follows US$1.0 billion […]
Canaccord Drops Beyond Meat Price Target To $80
On November 10th, Beyond Meat (NASDAQ: BYND) reported its third quarter results. The company reported revenues of$106.4 million down from $149.43 million last quarter. Gross profits also went the same way, dropping by roughly 50% to $23 million, from $47.35 million last quarter. The company reported adjusted EBITDA of -$36.8 million and a net loss […]
Lithium Americas’ Reflects Confidence That Cauchari-Olaroz Project Begins Production in Mid-2022
On November 17, Lithium Americas Corp. (TSX: LAC) reached an agreement to acquire Millennial Lithium Corp. (TSXV: ML) in a share-for-share exchange which values that company at $4.70 per share. Lithium Americas outbid China battery giant Contemporary Amperex Technology Co., Ltd. (CATL) to acquire Millennial, whose principal asset is the Pastos Grandes lithium brine development […]
Centerra Gold Recognizes US$926.4 Million Loss From Kumtor Mine Seizure
In the latest development related to the seized Kumtor mine, Centerra Gold Inc. (TSX: CG) reported on late Friday that it has filed a pertinent material change report on its SEDAR profile. The move is upon the request of the Ontario Securities Commission after its review of the recent developments. The mining firm is starting […]
Compass: Canaccord Reiterates $80 Price Target After Study Data
Earlier this month, Compass Pathways (Nasdaq: CMPS) announced positive topline results and its key findings in its Phase 2b clinical trial of COMP360 psilocybin therapy to treat depression. The study reportedly “achieved its primary endpoint for the highest dose, with a 25mg dose of COMP360 demonstrating a highly statistically significant and clinically relevant reduction in […]